|
|
Article: Affects serotonin, norepinephrine: FDA approves duloxetine for the treatment of major depressive disorder.(News)
- Article from:
- OB GYN News
- Article date:
- September 15, 2004
- Author:
CopyrightCOPYRIGHT 2004 International Medical News Group. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Approval of duloxetine hydrochloride by the Food and Drug Administration offers an additional drug for the treatment of major depressive disorder that affects both serotonin and norepinephrine.
In a statement announcing the approval, Dr. Stephen M. Stahl said duloxetine (Cymbalta), manufactured by Eli Lilly & Co., "offers physicians a new opportunity to help patients with depression, particularly those who experience the common physical symptoms of the disease, such as vague aches and pains."
But duloxetine "is not an analgesic, and it would be wrong to characterize it that way," Dr. Stahl told this newspaper.
Like selective serotonin reuptake ...